mLI9039

Model Information:

This model was developed from a transgenic mouse over expressing cMyc and Cre driven by the Alb gene promoter. The mouse developed liver cancer at the age of approximately 19 weeks.

Summary
Cancer Type	Liver Cancer
Mutations	H11-e(CAG-LSL-cmyc-polyA),Alb-Cre
Biopsy Site	Liver
Pathology QC	Hepatocellular carcinoma (P0, P1)
Mouse Strain	C57BL/6

Growth Characteristics

Additional Characteristics